In contrast, larger vessels from EGFR-expressing tumours were enriched for Birc2 (survivin), Socs2 (suppressor of cytokine signalling 2) and Srsf2 (serine and arginine-rich splicing factor 2). Here, EGFR is linked to neoplasm.